loadpatents
name:-0.036031007766724
name:-0.02255392074585
name:-0.007702112197876
CAI; Zeling Patent Filings

CAI; Zeling

Patent Applications and Registrations

Patent applications and USPTO patent grants for CAI; Zeling.The latest application filed is for "antibody-tumor necrosis factor alpha fusion protein and its preparation and applications".

Company Profile
7.23.29
  • CAI; Zeling - Shanghai CN
  • Cai; Zeling - San Diego CA US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
ANTIBODY-TUMOR NECROSIS FACTOR alpha FUSION PROTEIN AND ITS PREPARATION AND APPLICATIONS
App 20220098262 - CAI; Zeling ;   et al.
2022-03-31
CTLA-4 antibodies and uses thereof
Grant 11,208,483 - Cai , et al. December 28, 2
2021-12-28
Bispecific coupled antibody, preparation method and application thereof
Grant 11,021,538 - Cai , et al. June 1, 2
2021-06-01
Ctla-4 Antibodies And Uses Thereof
App 20200262921 - Cai; Zeling ;   et al.
2020-08-20
Fusion protein inhibiting TACI-BAFF complex formation and preparation method therefor and use thereof
Grant 10,562,954 - Cai , et al. Feb
2020-02-18
Acvr1-fc Fusion Protein, Preparation Method Therefor, And Application Thereof
App 20190062402 - CHEN; Yi ;   et al.
2019-02-28
Bispecific Coupled Antibody, Preparation Method And Application Thereof
App 20190048080 - Cai; Zeling ;   et al.
2019-02-14
Fusion Protein Inhibiting Taci-baff Complex Formation And Preparation Method Therefor And Use Thereof
App 20170081387 - Cai; Zeling ;   et al.
2017-03-23
Preparation of inactivated artificial antigen presenting cells and their use in cell therapies
Grant 8,357,533 - Cai , et al. January 22, 2
2013-01-22
Identification of antigenic peptides from multiple myeloma cells
Grant 8,323,655 - Cai , et al. December 4, 2
2012-12-04
Identification of antigenic peptides from multiple myeloma cells
Grant 8,323,965 - Cai , et al. December 4, 2
2012-12-04
Identification of antigenic peptides from multiple myeloma cells
Grant 8,232,101 - Cai , et al. July 31, 2
2012-07-31
Preparation Of Inactivated Artificial Antigen Presenting Cells And Their Use In Cell Therapies
App 20120115223 - Cai; Zeling ;   et al.
2012-05-10
Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
Grant 8,133,728 - Cai , et al. March 13, 2
2012-03-13
IgE antigenic peptides
Grant 8,133,972 - Cai , et al. March 13, 2
2012-03-13
Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
Grant 8,133,726 - Cai , et al. March 13, 2
2012-03-13
Preparation of inactivated artificial antigen presenting cells and their use in cell therapies
Grant 8,124,408 - Cai , et al. February 28, 2
2012-02-28
Identification Of Antigenic Peptides From Multiple Myeloma Cells
App 20120046645 - CAI; ZELING ;   et al.
2012-02-23
Identification Of Antigenic Peptides From Multiple Myeloma Cells
App 20120045466 - CAI; ZELING ;   et al.
2012-02-23
Identification Of Antigenic Peptides From Multiple Myeloma Cells
App 20120045829 - CAI; ZELING ;   et al.
2012-02-23
Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
Grant 8,106,153 - Cai , et al. January 31, 2
2012-01-31
Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
Grant 8,084,256 - Cai , et al. December 27, 2
2011-12-27
Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
Grant 8,084,253 - Cai , et al. December 27, 2
2011-12-27
Identification of antigenic peptides from multiple myeloma cells
Grant 8,075,895 - Cai , et al. December 13, 2
2011-12-13
Cancer treatment combining lymphodepleting agent with CTLs and cytokines
Grant 7,993,638 - Cai , et al. August 9, 2
2011-08-09
Identification Of Antigenic Peptides From Multiple Myeloma Cells
App 20110070185 - Cai; Zeling ;   et al.
2011-03-24
Ex-vivo Priming For Generating Cytotoxic T Lymphocytes Specific For Non-tumor Antigens To Treat Autoimmune And Allergic Disease
App 20110065186 - Cai; Zeling ;   et al.
2011-03-17
Ex-vivo Priming For Generating Cytotoxic T Lymphocytes Specific For Non-tumor Antigens To Treat Autoimmune And Allergic Disease
App 20110065180 - Cai; Zeling ;   et al.
2011-03-17
Ex-vivo Priming For Generating Cytotoxic T Lymphocytes Specific For Non-tumor Antigens To Treat Autoimmune And Allergic Disease
App 20110065187 - Cai; Zeling ;   et al.
2011-03-17
Ex-vivo Priming For Generating Cytotoxic T Lymphocytes Specific For Non-tumor Antigens To Treat Autoimmune And Allergic Disease
App 20110027301 - Cai; Zeling ;   et al.
2011-02-03
Ex-vivo Priming For Generating Cytotoxic T Lymphocytes Specific For Non-tumor Antigens To Treat Autoimmune And Allergic Disease
App 20110021747 - Cai; Zeling ;   et al.
2011-01-27
Ex-vivo Priming For Generating Cytotoxic T Lymphocytes Specific For Non-tumor Antigens To Treat Autoimmune And Allergice Disease
App 20110020309 - Cai; Zeling ;   et al.
2011-01-27
Ex-vivo Priming For Generating Cytotoxic T Lymphocytes Specific For Non-tumor Antigens To Treat Autoimmune And Allergic Disease
App 20110015370 - Cai; Zeling ;   et al.
2011-01-20
Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
Grant 7,842,501 - Cai , et al. November 30, 2
2010-11-30
Isolated CD8 .sup.+T lymphocytes specifically cytotoxic for a disease causing target cell
Grant 7,811,816 - Cai , et al. October 12, 2
2010-10-12
CANCER TREATMENT COMBINING LYMPHODEPLETING AGENT WITH CTLs AND CYTOKINES
App 20090324539 - Cai; Zeling ;   et al.
2009-12-31
Ex-vivo Priming For Generating Cytotoxic T Lymphocytes Specific For Non-tumor Antigens To Treat Autoimmune And Allergic Disease
App 20090202506 - Cai; Zeling ;   et al.
2009-08-13
Preparation of inactivated artificial antigen presenting cells and their use in cell therapies
App 20090017000 - Cai; Zeling ;   et al.
2009-01-15
Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
App 20070098734 - Cai; Zeling ;   et al.
2007-05-03
Enriched antigen-specific T-cells and related therapeutic and prophylactic compositions and methods
App 20060234310 - Cai; Zeling ;   et al.
2006-10-19
Antigen presenting system and methods for activation of T-cells
App 20050152916 - Cai, Zeling ;   et al.
2005-07-14
Antigen presenting system and methods for activation of T-cells
Grant 6,828,150 - Cai , et al. December 7, 2
2004-12-07
Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
App 20030170212 - Cai, Zeling ;   et al.
2003-09-11
Antigen presenting system and methods for activation of T-cells
App 20030138946 - Cai, Zeling ;   et al.
2003-07-24
Synthetic antigen presenting matrix
App 20030077318 - Cai, Zeling ;   et al.
2003-04-24
Antigen presenting system and methods for activation of T-cells
App 20030077708 - Cai, Zeling ;   et al.
2003-04-24
Synthetic antigen presenting matrix with liposome support
App 20030072796 - Cai, Zeling ;   et al.
2003-04-17
Synthetic antigen presenting matrix
Grant 6,461,867 - Cai , et al. October 8, 2
2002-10-08
Enriched antigen-specific-cells and related therapeutic and prophylactic compositions and methods
App 20020049302 - Cai, Zeling ;   et al.
2002-04-25
Method for producing a synthetic antigen presenting transformed Drosophila cell
Grant 6,362,001 - Cai , et al. March 26, 2
2002-03-26
Antigen presenting system and methods for activation of T-cells
Grant 6,225,042 - Cai , et al. May 1, 2
2001-05-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed